Patient Safety
-
New UC Treatment Update: Safety Fears Cleared for Obefazimod
A large-scale safety analysis of the new ulcerative colitis drug obefazimod shows no increased cancer risk,…
-
Weight-Loss Medicines and Crohn’s: Can They Help Your Gut?
GLP-1 receptor agonist use was associated with lower steroid dependence and clinical outcomes in adults with…
-
New Study Compares Hospital Admissions for Ileostomies and Colostomies
Patients with ileostomies had higher rates of readmissions due to stoma-related complications. Readmissions due to dehydration…
-
Understanding J-Pouch Risks: New Findings for Patients with Pyoderma Gangrenosum
Patients with pyoderma gangrenosum had an almost six times higher risk of pouch failure”. “identifying high-risk…
IBD Science for Patients 